Pacitti David 4

What Happened
David Pacitti, CEO of Avanos Medical, surrendered 21,194 shares of common stock at $14.53 per share (total ≈ $307,949) on April 14, 2026. The shares were surrendered to the company to satisfy tax withholding obligations tied to the vesting of restricted share units (TRSUs), not sold on the open market.

Key Details

• Transaction date: April 14, 2026; filing date (Form 4): April 16, 2026.
• Price/amount: 21,194 shares surrendered at $14.53 each; total value ≈ $307,949.
• Shares owned after transaction: Filing does not state total post-transaction holdings; the vesting involved 72,614 TRSUs, so net delivered to the insider after withholding = 72,614 − 21,194 = 51,420 shares.
• Footnote: TRSUs were awarded April 14, 2025 and vested April 14, 2026; each TRSU equals one share (footnote F1).
• Transaction code: F — shares surrendered to satisfy tax withholding (not an open-market sale).
• Timeliness: Filed two days after the transaction (not marked late).

Context
This was a routine tax-withholding transaction on vested restricted stock units (a common "cashless" surrender), which should not be read as a discretionary sale signaling sentiment. TRSUs convert to shares upon vesting; the company retained a portion to cover taxes rather than the insider selling shares on the market.